Long term disease control using taxane/platinum-based chemotherapy in CDK12-mutated advanced prostate cancer.

Long term disease control using taxane/platinum-based chemotherapy in CDK12-mutated advanced prostate cancer. Oncologist. 2020 Jun 27;: Authors: Barata P, Ledet E, Manogue C, Cotogno P, Harris K, Lewis B, Layton J, Sartor O PMID: 32592623 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32592623?dopt=Abstract

Source: The Oncologist - June 26, 2020 Category: Cancer & Oncology Authors: Barata P, Ledet E, Manogue C, Cotogno P, Harris K, Lewis B, Layton J, Sartor O Tags: Oncologist Source Type: research

More News: Cancer | Cancer & Oncology | Chemotherapy | Prostate Cancer